Cabot Co. (NYSE:CBT - Get Rating) - Analysts at Zacks Research issued their FY2025 earnings estimates for Cabot in a report issued on Monday, November 21st. Zacks Research analyst A. Barman expects that the specialty chemicals company will post earnings of $5.85 per share for the year. The consensus estimate for Cabot's current full-year earnings is $6.53 per share.
Several other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of Cabot from a "hold" rating to a "buy" rating and upped their price objective for the company from $80.00 to $90.00 in a report on Wednesday, November 16th. StockNews.com assumed coverage on shares of Cabot in a report on Wednesday, October 12th. They set a "buy" rating on the stock. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $83.25.
Cabot Price Performance
Shares of NYSE CBT opened at $73.80 on Thursday. The firm's 50-day moving average price is $69.05 and its 200-day moving average price is $69.82. Cabot has a 1-year low of $50.96 and a 1-year high of $78.62. The firm has a market capitalization of $4.15 billion, a P/E ratio of 20.50 and a beta of 1.39. The company has a current ratio of 1.65, a quick ratio of 1.05 and a debt-to-equity ratio of 1.06.
Institutional Investors Weigh In On Cabot
A number of institutional investors and hedge funds have recently made changes to their positions in CBT. Truist Financial Corp bought a new position in shares of Cabot in the first quarter valued at approximately $237,000. SG Americas Securities LLC increased its position in Cabot by 76.1% in the first quarter. SG Americas Securities LLC now owns 24,553 shares of the specialty chemicals company's stock worth $1,680,000 after buying an additional 10,609 shares during the last quarter. Mutual of America Capital Management LLC increased its position in Cabot by 1.7% in the first quarter. Mutual of America Capital Management LLC now owns 51,604 shares of the specialty chemicals company's stock worth $3,530,000 after buying an additional 864 shares during the last quarter. Envestnet Asset Management Inc. increased its position in Cabot by 11.7% in the first quarter. Envestnet Asset Management Inc. now owns 80,655 shares of the specialty chemicals company's stock worth $5,518,000 after buying an additional 8,436 shares during the last quarter. Finally, Advisor Group Holdings Inc. increased its position in Cabot by 18.1% in the first quarter. Advisor Group Holdings Inc. now owns 11,328 shares of the specialty chemicals company's stock worth $773,000 after buying an additional 1,740 shares during the last quarter. Institutional investors and hedge funds own 96.48% of the company's stock.
Cabot Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 9th. Investors of record on Friday, November 25th will be issued a $0.37 dividend. The ex-dividend date of this dividend is Wednesday, November 23rd. This represents a $1.48 dividend on an annualized basis and a dividend yield of 2.01%. Cabot's dividend payout ratio is presently 41.11%.
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to email@example.com.
Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here